Constellation Brands Faces Challenges Amid Market Fluctuations

Constellation Brands, Inc. (STZ), a $34.2 billion company, produces, imports, markets, and sells beer, wine, and spirits across the United States, Canada, Mexico, New Zealand, and Italy. Established in 1945 and headquartered in Victor, New York, Constellation brands its products for wholesale distributors, retailers, on-premise locations, and state alcohol beverage control agencies.

As a large-cap stock, Constellation Brands exceeds the $10 billion threshold, holding a significant position within the beverage industry. With notable brands like Corona, Modelo, and SVEDKA, the company occupies a prominent spot in the global market.

Recent Stock Performance

Despite its robust market standing, STZ has faced a downturn, declining 32.6% from its 52-week high of $274.87 recorded on April 11. Over the last three months, shares have dropped 22.8%, underperforming the broader Dow Jones Industrial Average (DOWI), which saw a decline of 6.2% during the same period.

In the past six months, STZ shares have decreased by 25.5%, contrasting sharply with DOWI’s modest gain of 1.4%. Over the last 52 weeks, STZ shares have fallen 29.3%, while DOWI has managed a 6.9% rally.

Technical Indicators

Trading below its 200-day moving average since early October, STZ remains above its 50-day moving average, which it has traded above since early March.

Market Challenges

Constellation Brands’ recent underperformance stems from sluggish consumer spending affecting the company’s top-line growth. Following disappointing Q3 earnings released on January 10, where net sales reached $2.5 billion and earnings per share fell short of Wall Street estimates by 2.7%, STZ shares dipped by 17.1%. These factors, alongside rising inflation concerns, have compounded the company’s challenges.

Industry Competition

Amid these difficulties, Constellation Brands faces competition from Compañía Cervecerías Unidas S.A. (CCU), which has seen its shares surge 40.7% over the past six months and 20.3% over the past year.

Nonetheless, analysts maintain a cautiously optimistic outlook for STZ. The stock holds a consensus rating of “Moderate Buy” from 22 analysts, with a mean price target of $237.61, suggesting an upside of 28.3% from current market prices.

On the date of publication, Kritika Sarmah did not hold any positions in the securities mentioned. All information and data in this article are for informational purposes only. For more details, please view the Barchart Disclosure Policy here.

 

More news from Barchart

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.